New heart scan could predict which patients benefit from popular drug
NCT ID NCT07178145
Summary
This study aims to develop a better MRI scan to measure the type of fat around the heart. Researchers will use this new scan in people with a common form of heart failure to see if the fat's makeup is linked to their condition. They will also test if this scan can predict who might improve when taking the diabetes medication semaglutide.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia
Charlottesville, Virginia, 22903, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.